Trial Profile
The efficacy combined therapy with silodosin and solifenasin in female overactive bladder patients with voiding symptom
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Silodosin (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 16 Nov 2018 New trial record